Michael P Palmer1, Daniel T Altman, Gregory T Altman, Jeffrey J Sewecke, Garth D Ehrlich, Fen Z Hu, Laura Nistico, Rachel Melton-Kreft, Trent M Gause, John W Costerton. 1. *Department of Orthopaedic Surgery, Allegheny General Hospital, Pittsburgh, PA; †Department of Orthopaedic Surgery, Allegheny General Hospital, Drexel University College of Medicine and Temple University School of Medicine, Pittsburgh, PA; ‡Division of Orthopaedic Trauma, Allegheny General Hospital, Pittsburgh, PA; §Department of Orthopaedic Surgery, Temple University School of Medicine, Pittsburgh, PA; ‖Department of Orthopaedic Surgery, Drexel University College of Medicine, Pittsburgh, PA; ¶Center for Genomic Sciences, Allegheny-Singer Research Institute, Pittsburgh, PA; **Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA; and ††Penn State University, State College, PA.
Abstract
OBJECTIVES: To identify the presence of bacterial biofilms in nonunions comparing molecular techniques (multiplex polymerase chain reaction and mass spectrometry, fluorescent in situ hybridization) with routine intraoperative cultures. METHODS: Thirty-four patients with nonunions were scheduled for surgery and enrolled in this ongoing prospective study. Intraoperative specimens were collected from removed implants, surrounding tissue membrane, and local soft tissue followed by standard culture analysis, Ibis's second generation molecular diagnostics (Ibis Biosystems), and bacterial 16S rRNA-based fluorescence in situ hybridization (FISH). Confocal microscopy was used to visualize the tissue specimens reacted with the FISH probes, which were chosen based on the Ibis analysis. RESULTS: Thirty-four patient encounters were analyzed. Eight were diagnosed as infected nonunions by positive intraoperative culture results. Ibis confirmed the presence of bacteria in all 8 samples. Ibis identified bacteria in a total of 30 of 34 encounters, and these data were confirmed by FISH. Twenty-two of 30 Ibis-positive samples were culture-negative. Four samples were negative by all methods of analysis. No samples were positive by culture, but negative by molecular techniques. CONCLUSIONS: Our preliminary data indicate that molecular diagnostics are more sensitive for identifying bacteria than cultures in cases of bony nonunion. This is likely because of the inability of cultures to detect biofilms and bacteria previously exposed to antibiotic therapy. LEVEL OF EVIDENCE: Diagnostic Level I. See Instructions for Authors for a complete description of levels of evidence.
OBJECTIVES: To identify the presence of bacterial biofilms in nonunions comparing molecular techniques (multiplex polymerase chain reaction and mass spectrometry, fluorescent in situ hybridization) with routine intraoperative cultures. METHODS: Thirty-four patients with nonunions were scheduled for surgery and enrolled in this ongoing prospective study. Intraoperative specimens were collected from removed implants, surrounding tissue membrane, and local soft tissue followed by standard culture analysis, Ibis's second generation molecular diagnostics (Ibis Biosystems), and bacterial 16S rRNA-based fluorescence in situ hybridization (FISH). Confocal microscopy was used to visualize the tissue specimens reacted with the FISH probes, which were chosen based on the Ibis analysis. RESULTS: Thirty-four patient encounters were analyzed. Eight were diagnosed as infected nonunions by positive intraoperative culture results. Ibis confirmed the presence of bacteria in all 8 samples. Ibis identified bacteria in a total of 30 of 34 encounters, and these data were confirmed by FISH. Twenty-two of 30 Ibis-positive samples were culture-negative. Four samples were negative by all methods of analysis. No samples were positive by culture, but negative by molecular techniques. CONCLUSIONS: Our preliminary data indicate that molecular diagnostics are more sensitive for identifying bacteria than cultures in cases of bony nonunion. This is likely because of the inability of cultures to detect biofilms and bacteria previously exposed to antibiotic therapy. LEVEL OF EVIDENCE: Diagnostic Level I. See Instructions for Authors for a complete description of levels of evidence.
Authors: Carlos J Sanchez; Stefanie M Shiels; David J Tennent; Sharanda K Hardy; Clinton K Murray; Joseph C Wenke Journal: Clin Orthop Relat Res Date: 2015-09 Impact factor: 4.176
Authors: J Curtis Nickel; Alisa Stephens; J Richard Landis; Jun Chen; Chris Mullins; Adrie van Bokhoven; M Scott Lucia; Rachael Melton-Kreft; Garth D Ehrlich Journal: J Urol Date: 2015-01-14 Impact factor: 7.450
Authors: Vivek Chadayammuri; Benoit Herbert; Jiandong Hao; Andreas Mavrogenis; Juan C Quispe; Ji Wan Kim; Heather Young; Mark Hake; Cyril Mauffrey Journal: Eur J Orthop Surg Traumatol Date: 2017-05-25
Authors: J Curtis Nickel; Alisa Stephens; J Richard Landis; Chris Mullins; Adrie van Bokhoven; M Scott Lucia; Garth D Ehrlich Journal: J Urol Date: 2015-09-26 Impact factor: 7.450
Authors: Stephen J McConoughey; Rob Howlin; Jeff F Granger; Maurice M Manring; Jason H Calhoun; Mark Shirtliff; Sandeep Kathju; Paul Stoodley Journal: Future Microbiol Date: 2014 Impact factor: 3.165